TI
XERS icon

Trexquant Investment’s Xeris Biopharma Holdings XERS Stock Holding History

Trexquant Investment’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.69M Sell
339,113
-494,104
-59% -$3.16M 0.02% 1061
2026
Q1 		$4.83M Buy
833,217
+619,636
+290% +$4.11M 0.03% 662
2025
Q4 		$1.68M Sell
213,581
-15,839
-7% -$125K 0.01% 1046
2025
Q3 		$1.87M Buy
+229,420
New +$1.52M 0.02% 930
2021
Q2 		– Sell
-35,438
Closed -$160K – 1557
2021
Q1 		$160K Buy
+35,438
New +$191K 0.01% 1014

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Trexquant Investment's XERS Position: Q2 2026 in Review

Trexquant Investment reduced its Xeris Biopharma Holdings (XERS) stake by 59% in Q2 2026, selling an estimated $3.16M and leaving 339,113 shares worth $2.69M. The position accounts for 0.02% of the portfolio, ranked #1061.

Trexquant Investment first reported a position in XERS in Q1 2021 and has held it in 5 quarters since. The position peaked at $4.83M in Q1 2026. 241 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Trexquant Investment held 339,113 shares of Xeris Biopharma Holdings worth $2.69M as of Q2 2026.
  • Trexquant Investment sold 494,104 Xeris Biopharma Holdings shares in Q2 2026, an estimated $3.16M.
  • Xeris Biopharma Holdings made up 0.02% of Trexquant Investment's portfolio in Q2 2026, its #1061 holding.
  • Trexquant Investment first reported a position in Xeris Biopharma Holdings in Q1 2021 and has held it in 5 quarters since.
  • Trexquant Investment's Xeris Biopharma Holdings position peaked at $4.83M in Q1 2026.
  • 241 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.